RVTY

SELL

Revvity, Inc.

Healthcare · Rank #344 · Analyzed Oct 18, 2026

$152.64

Current Price

$22.45

Intrinsic Value

-85.3%

Upside/Downside

2/10

Score

2/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score2/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 85.3%

Fair Value Range

Low$21.32

Base (IV)$22.45

High$36.51

Entry Points

Conservative$14.93

Moderate$21.32

Aggressive$15.72

Quality & Moat Breakdown

Return on Equity3.2% → 0/1.0

Debt LevelD/E 46 → 0.5/1.0

Revenue QualityGrowth 6.1%, margin Δ-5.2% +recovery → 1.0/1.0

Moat Strength1.5/5 → 0/1.0

Profit Margins8.2% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.